| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |